CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

Funding Opportunity

hand holding coins with a sprout coming outCAGT Fellowship 2021-2022

We are excited to provide fellowships that support postdoctoral trainees conducting research to develop genomic technologies and methods for associated computational analyses, as well as applying these technologies to basic and applied biomedical sciences. Genome Technology Fellows will receive support for two years and participate in mentored research with topics to be determined by the fellow and faculty advisor(s) based on mutual interests. 
Deadline: August 31

More information »

In the News

Nasdaq highlights Xilis on their tower in Times Square

July 12, 2021 | Duke Translation & Commercialization

Cancer treatment startup started by Duke faculty raises $70M

Charlie Gersbach

June 29, 2021

Gersbach Awarded Distinguished Professorship

Charlie Gersbach has been awarded the John W. Strohbehn Distinguished Professor of Biomedical Engineering, effective July 1, 2021. Appointment to a named chair recognizes excellence in research, teaching and contributions to the university community.  Gerbach is one of 22 Duke faculty to receive a [...]

June 16, 2021 | Pratt School of Engineering

Cells Construct Living Composite Polymers for Biomedical Applications